Gergen Mark J 4
4 · Poseida Therapeutics, Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Gergen Mark J
DirectorExecutive Chairman
Transactions
- Tax Payment
Common Stock
2024-02-01$3.41/sh−47,162$160,822→ 685,448 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on February 1, 2022.